Biomea Fusion, Inc. (BMEA) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Biomea Fusion, Inc.
Biomea Fusion, Inc. is led by CEO Michael J. Hitchcock, employs 79 people, headquartered in US, publicly traded since 2021.
Biomea Fusion, Inc. (BMEA) stock trades at $0.60 with a market capitalization of $43.39M. The stock is valued at a negative price-to-earnings (P/E) ratio of -2.56, reflecting a net loss over the last twelve months, price-to-book of 7.57, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.59 and $2.99, and currently trades 79.9% below its 52-week high.
On profitability, Biomea Fusion, Inc. generates a return on equity (ROE) of -171.19% (negative, reflecting a net loss), return on capital employed of -220.02%.
Biomea Fusion, Inc. by the numbers, 2019–2025
Between 2019 and 2025 Biomea Fusion, Inc. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-62.0M.
On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-31.0M.
Borrowings stand at $2.0M, cash from operations was $-70.0M in the latest year, positive in 0 of the last 7.
Return on equity has averaged -128.0% over five years, and was -206.7% in the most recent year.
The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Biomea Fusion, Inc. (BMEA) — frequently asked questions
What is Biomea Fusion, Inc. (BMEA) stock price today?
Biomea Fusion, Inc. (BMEA) is currently trading at $0.60, up 2.58% today.
What is BMEA P/E ratio?
Biomea Fusion, Inc.'s P/E ratio is -2.56. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is BMEA return on equity (ROE)?
Biomea Fusion, Inc.'s return on equity (ROE) is -171.19%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Biomea Fusion, Inc.'s market cap?
Biomea Fusion, Inc. has a market capitalization of $43.39M.
Does BMEA pay a dividend?
Biomea Fusion, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does BMEA carry?
Biomea Fusion, Inc. has a debt-to-equity ratio of 0.07. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is BMEA's profit margin?
Biomea Fusion, Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is BMEA in?
Biomea Fusion, Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is BMEA listed on?
Biomea Fusion, Inc. trades on NASDAQ under the ticker BMEA.
What is BMEA's 52-week range?
Over the last year Biomea Fusion, Inc. has traded between $0.59 and $2.99.
Related Healthcare Stocks
Popular Stocks
Screens BMEA currently matches
On the figures above, Biomea Fusion, Inc. passes the filters for 3 of our ready-made screens, among them Penny Stocks, Stocks Under $1, Nano Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.